During tumor progression, the thymic T-cell differentiation process appears to be negatively impacted by the silencing of Notch1 signaling (45) and corollary expression of Notch1-downstream target ccr7 (19, 46), along with its two ligands CCL19 and CCL21 within thymus. This evidence concerns the gene CCL21 and neoplasm.